The Role of Fibrinolytic Activity of Blood Plasma in the Development of Obstetric Complications in Overweight Pregnant Women with Metabolic Dysfunction-Associated Steatohepatitis: A Prospective Cohort Study
Background: Obesity and hyperlipidaemia during pregnancy increase the risk of metabolic dysfunction-associated steatotic liver disease. Our aim was to evaluate changes in the fibrinolytic system in overweight pregnant women due to metabolic dysfunction-associated steatohepatitis, compared with a con...
Saved in:
Main Authors: | Lina Bahniy (Author), Svitlana Heryak (Author), Nataliya Bahniy (Author), Viktoriia Kuchmii (Author) |
---|---|
Format: | Book |
Published: |
IMR Press,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The adiponectin‐derived peptide ALY688 protects against the development of metabolic dysfunction‐associated steatohepatitis
by: Zhe Huang, et al.
Published: (2024) -
Primary Care Utilization, Preventative Screening, and Control of Metabolic Syndrome in Metabolic Dysfunction-Associated Steatohepatitis Liver Transplant Recipients
by: Sarah J. Flynn MD, MPhil, et al.
Published: (2024) -
Imeglimin Halts Liver Damage by Improving Mitochondrial Dysfunction in a Nondiabetic Male Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis
by: Kosuke Kaji, et al.
Published: (2024) -
Metabolic comorbidity, the new enemy. Metabolic syndrome and steatohepatitis
by: JM Rivera Esteban, et al. -
The Role of Fibrinolytic System in Health and Disease
Published: (2022)